AI-guided cognitive behavioral therapy for depression and anxiety
Official title: The Significance of Artificial Intelligence-Guided Psychotherapy of Depression and Anxiety Disorders
Run by Clinical Center Niš · NCT07576686 · Data updated 2026-11-12
This program will try an AI-guided online CBT to see if it helps adults with mild depression or anxiety.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Clinical Center Niš Academic / other |
| Locations | 1 site (Niš) |
| Status | Recruiting |
| Started | January 7, 2026 |
| Main results expected | May 15, 2026 |
| Study ends | June 10, 2026 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT07576686 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with a confirmed diagnosis of mild depressive disorder and/or an anxiety disorder who can use a smartphone, tablet, or computer and are willing to attend weekly 10-week sessions are ideal candidates.
✕Probably not a fit
People with moderate to severe depression, bipolar disorder, psychotic disorders, severe cognitive impairment, acute suicidal risk, or those unable to use digital tools are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This controlled clinical trial will compare an AI-guided cognitive behavioral therapy program delivered via a digital platform with standard psychiatric care in adults with mild depressive and/or anxiety disorders. Eligible participants recruited from outpatient services at the University Clinical Center Niš will be allocated to either the AI-guided CBT arm or a control arm receiving usual care. The intervention consists of weekly 45–60 minute structured sessions over 10 weeks, delivered through the digital platform with clinician supervision. Outcomes will be measured at baseline, mid-treatment (5 weeks), and post-treatment (10 weeks).
Why it matters
Potential benefit: If successful, the program could expand access to evidence-based CBT by providing a scalable, AI-supported option for people with mild depression or anxiety.
How similar studies have gone: Previous digital and guided CBT programs have shown effectiveness for mild-to-moderate depression and anxiety, though fully AI-guided approaches remain relatively new and are still being tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age 18 years or older Diagnosis of mild depressive disorder and/or anxiety disorder confirmed by a structured clinical interview (MINI) Ability to understand and provide informed consent Access to a device capable of using the digital platform (computer, tablet, or smartphone) Willingness to participate in weekly sessions over a 10-week period Exclusion Criteria: Moderate to severe depressive disorder Current or past diagnosis of psychotic disorder Bipolar disorder Substance use disorder or dependence Primary diagnosis of antisocial personality disorder Severe cognitive impairment or inability to use digital tools Acute suicidal risk requiring immediate intervention Concurrent participation in another structured psychotherapy program-
Where it's running
-
University Clinical Center Niš
Niš, Serbia Recruiting
Study contacts
- Study coordinator: Aleksandra Stojanovic, MD, PhD Candidate
- Email: drakiwatson@gmail.com
- Phone: +381642293541
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Understanding how the orbitofrontal cortex guides approach vs. avoidance in depression
This study tests how different parts of the orbitofrontal cortex influence whether people pursue rewards or risk loss, and whether this pattern is altered in Major Depressive Disorder.
-
Health education program to help depression in older adults and caregivers in Ho Chi Minh City
A community-based education program for people 60+ and their caregivers is being tested to see if it can lower depression and improve quality of life compared with standard care.
-
Prucalopride for low mood: testing a 5-HT4 receptor activator for cognition and sleep
This study tests whether prucalopride, a 5-HT4 receptor drug, can improve thinking and sleep in adults with low mood or major depressive disorder compared to a placebo.
-
Pre-visit Companion Brief: a primary care AI-assisted check for depression and anxiety
This pilot tests an AI-powered pre-visit assessment that creates a concise Companion Brief for clinicians to help identify depression and anxiety during routine primary care.
-
See if personalized CBM-I can help anxious kids ages 10–17
Aimed at youth with Generalized, Separation, or Social Anxiety, the study tests a personalized cognitive bias modification for interpretation (CBM-I) to see if it reduces threat-focused thinking and anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.